Green tea epigallocatechin-3-gallate inhibits platelet signalling pathways triggered by both proteolytic and non-proteolytic agonists

Summary

Epigallocatechin-3-gallate (EGCG), a component of green tea, inhibits human platelet aggregation and cytosolic [Ca²⁺]_cincreases more strongly when these processes are induced by thrombin than by the non-proteolytic thrombin receptor activating peptide (TRAP), thromboxane mimetic U46619, or fluoroaluminate. In line with the previously demonstrated EGCG anti-proteolytic activity, a marked inhibition on aggregation is obtained by pre-incubation of thrombin with EGCG prior to addition to cellular suspension. The catechin also reduces cellular Ca²⁺ influx following thapsigargin-induced calcium emptying of endoplasmic reticulum, and the agonist-promoted cellular protein tyrosine phosphorylation. Both tyrosine kinases Syk and Lyn, immuno-precipitated from stimulated platelets, are greatly inhibited upon cellular pre-incubation with EGCG, which also inhibits the in vitro auto-phosphorylation and exogenous activity of these two enzymes purified from rat spleen. Both thrombin-induced aggregation and [Ca²⁺]_c increase are reduced in platelets from rats that drank green tea solutions. It is concluded that EGCG inhibits platelet activation, by hindering the thrombin proteolytic activity, and by reducing the agonist-induced [Ca²⁺]_cincrease through inhibition of Syk and Lyn activities.

Keywords

Epigallocatechin-3-gallate (EGCG) - thrombin proteolytic activity - platelet cytosolic Ca²⁺ - non-receptor tyrosine kinases

• References

• 1 Lapetina EG.. The signal transduction by thrombin in human platelets. FEBS Lett 1990; 268: 400-4.
• 2 Clemetson KJ.. Platelet activation: signal transduction via membrane receptor. Thromb Haemost 1995; 74: 111-6.
• 3 Francesconi M, Casonato A, Pontara E.. et al. Type IIB von Willebrand factor induces phospholipase A₂ activation and cytosolic Ca²⁺ increase in platelets. Biochem Biophys Res Commun 1995; 214: 102-9.
• 4 Brass LF, Manning DR, Cichowski K, Abrams CS.. Signaling through G proteins in platelets: to the integrins and beyond. Thromb Haemost 1997; 78: 581-9.
• 5 Randriamampita C, Tsien RY.. Emptying of intracellular Ca²⁺ stores releases a novel small messenger that stimulates Ca²⁺ influx. Nature 1993; 364: 809-14.
• 6 Feinstein MB, Pumiglia K, Lau L-F.. Tyrosine phosphorylation in platelets: its regulation and possible role in platelet functions. In: Mechanisms of platelet activation and control. Authi KS, Watson SP, Kakkar VV.. eds New York NY: Plenum Press; 1993: 129-48.
• 7 Jackson SP, Schoenwaelder SM, Yuan Y, Salem HH, Cooray P.. Non-receptor protein tyrosine kinases and phosphatases in human platelets. Thromb Haemost 1996; 76: 640-50.
• 8 Brass LF, Shattil SJ.. Inhibition of thrombin-induced platelet activation by leupeptin. Implications for the participation of calpain in the initiation of platelet activation. J Biol Chem 1988; 263: 5210-6.
• 9 Wu T-KH, Hung DT, Wheaton VI, Coughlin SR.. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-68.
• 10 Grand RJA, Turnell AS, Grabham PW.. Cellular consequences of thrombin-receptor activation. Biochem J 1996; 313: 353-68.
• 11 Sambrano GR, Weiss EJ, Zheng Y-W, Huang W, Coughlin S.. Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature 2001; 413: 74-8.
• 12 Vassallo Jr RR, Kieber-Emmons T, Cichowski K, Brass L.. Structure-function relationship in the activation of platelet thrombin receptor by receptor-derived peptides. J Biol Chem 1992; 267: 6081-5.
• 13 Rendu F, Lebret M, Tenza D, Levy-Toledano S.. How does fluoroaluminate activate human platelets?. Biochem J 1990; 265: 343-9.
• 14 Doni MG, Deana R, Padoin E.. et al. Platelet activation by diacylglycerol or ionomycin is inhibited by nitroprusside. Biochim Biophys Acta 1991; 1094: 323-9.
• 15 Weiss HJ... Antiplatelet drugs and therapy. In Williams Hematology. Beutler E, Licthman MA, Coller BS, Kipps TJ.. eds. Fifth edn New York, NY: McGraw-Hill; 1995: 1550-62.
• 16 Kang W-S, Lim I-H, Yuk D-Y.. et al. Antithrombotic activities of green tea cate-chins and (-)epigallocatechin gallate. Thromb Res 1999; 96: 229-37.
• 17 Kang W-S, Chung K-H, Chung J-H.. et al. Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase. J Cardiovasc Pharmacol 2001; 38: 875-84.
• 18 Cao Y, Cao R.. Angiogenesis inhibited by drinking tea. Nature 1999; 398: 81.
• 19 Garbisa S, Biggin S, Cavallarin N, Sartor L, Benelli R, Albini A.. Tumor invasion: molecular shears blunted by green tea. Nat Med 1999; 5: 1216.
• 20 Garbisa S, Sartor L, Biggin S.. et al. Tumor gelatinases and invasion inhibited by green tea flavanol epigallocatechin-3-gallate. Cancer 2001; 91: 822-32.
• 21 Demeule M, Michaud-Levesque J, Annabi B.. et al. Green tea catechins as novel antitumor and antiangiogenic compounds. Curr Med Chem Anti-Cancer Agents 2002; 2: 441-63.
• 22 Sartor L, Pezzato E, Garbisa S.. (-) Epigallocatechin-3-gallate inhibits leukocyte elastase: potential of the phyto-factor in hindering inflammation, emphysema, and invasion. J Leukoc Biol 2002; 71: 73-9.
• 23 Negro A.. et al. Multiple phosphorylation of α-synuclein by protein tyrosine kinase Syk prevents eosin-induced aggregation. FASEB J 2002; 16: 210-2.
• 24 Cavallini L, Francesconi MA, Ruzzene M, Valente M, Deana R.. A procedure allowing measurement of cytosolic Ca²⁺ in rat platelets. Inhibition of plasma lipoprotein on fura 2-AM loading. Thromb Res 1991; 63: 47-57.
• 25 Brunati AM.. et al. Site specificity of p72syk protein tyrosine kinase. Efficient phosphorylation of motifs recognized by Src homology 2 domains of the Src family. FEBS Lett 1995; 367: 149-52.
• 26 Donella-Deana A.. et al. Isolation from spleen of a 57-kDa protein substrate of the tyrosine kinase Lyn. Identification as a protein related to protein disulfide-isomerase and localization of the phosphorylation sites. Eur J Biochem 1996; 235: 18-25.
• 27 Marin O, Donella-Deana A, Brunati AM, Fischer S, Pinna LA.. Peptides reproducing the phosphoacceptor sites of pp60c-src as substrates for TPK-IIB, a splenic tyrosine kinase devoid of autophosphorylation activity. J Biol Chem 1991; 266: 17798-803.
• 28 Brunati AM, James P, Guerra B.. et al. The spleen protein-tyrosine kinase TPK-IIB is highly similar to the catalytic domain of p72^Syk . Eur J Biochem 1996; 240: 400-7.
• 29 Meggio F, Donella A, Pinna LA.. A new procedure for the measurement of the protein-kinase-catalyzed incorporation of the γ-³²Pphosphoryl group of ATP into phosphoproteins and phosphopeptides. Anal Biochem 1976; 71: 583-7.
• 30 Yang CS, Wang Z-Y.. Tea and Cancer. J Natl Cancer Inst 1993; 85: 1038-49.
• 31 Maeda-Yamamoto M, Kawahara H.. et al. Effects of tea polyphenols on the invasion and matrix metalloproteinases activities of human fibrosarcoma HT1080 cells. J Agric Food Chem 1999; 47: 2350-4.
• 32 Turetta L, Bazzan E, Bertagno K, Musacchio E, Deana R.. Role of Ca²⁺ and protein kinase C in the serotonin (5-HT) transport in human platelets. Cell Calcium 2002; 31: 235-44.
• 33 Clark EA, Shattil SJ, Brugge JS.. Regulation of protein tyrosine kinases in platelets. Trends Biochem Sci 1994; 19: 464-9.
• 34 Twamley GM, Courtneidge SA.. Non-receptor protein tyrosine kinases. In: Protein phosphorylation. Marks F.. ed Weinheim: VCM; 1996: 237-64.
• 35 Achison M, Elton CM, Hargreaves PG.. et al. Integrin-independent tyrosine phosphorylation of p125(Fak) in human platelets stimulated by collagen. J Biol Chem 2001; 276: 3167-76.
• 36 Maguire PB.. et al. Identification of the phosphotyrosine proteome from thrombin activated platelets. Proteomics 2002; 2: 642-8.
• 37 Cho MJ.. et al. Role of the Src family kinase Lyn in TxA2 production, adenosine diphosphate secretion, Akt phosphorylation, and irreversible aggregation in platelets stimulated with gamma-thrombin. Blood 2002; 99: 2442-7.
• 38 Chintala MS, Chiu PJS, Bernardino V.. et al. Disparate effects of thrombin receptor activating peptide on platelets and peripheral vasculature in rats. Eur J Pharmacol 1998; 349: 237-43.
• 39 Hong J, Lu H, Meng X.. et al. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res 2002; 62: 7241-6.
• 40 Liu JD, Chen SH, Lin CL, Tsai SH, Liang YC.. Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice. J Cell Biochem 2001; 83: 631-42.
• 41 Masuda M, Suzui M, Weinstein IB.. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 2001; 7: 4220-9.
• 42 Sachinidis A, Seul C, Seewald S, Ahn H, Ko Y, Vetter H.. Green tea compounds inhibit tyrosine phosphorylation of PDGF beta-receptor and transformation of A172 human glioblastoma. FEBS Lett 2000; 471: 51-5.
• 43 Sachidis A, Skach RA, Seul C.. et al. Inhibition of PDGF beta-receptor tyrosine phosphorylation and its downstream intracellular signal transduction pathway in rat and human vascular smooth muscle cells by different catechins. FASEB J 2002; 16: 893-5.
• 44 Vostal JG, Jackson WL, Shulman NR... Cytosolic and stored calcium antagonistically control tyrosine phosphorylation of specific platelet proteins. J Biol Chem 1991; 266: 16911-6.
• 45 Wang X, Sada K, Yanagi S, Yang C, Rezaul K, Yamamura H.. Intracellular calcium dependent activation of p72syk in platelets. J Biol Chem 1994; 116: 858-61.
• 46 Dash D, Aepfelbacher M, Siess W.. The association of pp125FAK, pp60Src, CDC42Hs and Rap1B with the cytoskeleton of aggregated platelets is a reversible process regulated by calcium. FEBS Lett 1995; 363: 231-4.
• 47 Dalla Via L.. et al. Correlation between cytosolic Ca²⁺ concentration, protein phosphorylation and platelet secretion. Cell Calcium 1996; 20: 431-40.
• 48 Sargeant P, Farndale RW, Sage SO.. ADP- and thapsigargin-evoked Ca²⁺ entry and protein-tyrosine phosphorylation are inhibited by the tyrosine kinase inhibitors genistein and methyl-2,5-dihydroxycinnamate in fura-2-loaded human platelets. J Biol Chem 1993; 268: 18151-6.
• 49 Guinebault C, Payrastre B, Sultan C.. et al. Tyrosine kinases and phosphoinositide metabolism in thrombin-stimulated human platelets. Biochem J 1993; 292: 851-6.
• 50 Jayaraman T, Ondrias K, Ondriasova E, Marks AR.. Regulation of the inositol 1,4,5-trisphosphate receptor by tyrosine phosphorylation. Science 1996; 272: 492-4.
• 51 Dean WL.. et al. Regulation of platelet plasma membrane Ca²⁺-ATPase by cAMP-dependent and tyrosine phosphorylation. J Biol Chem 1997; 272: 15113-9.
• 52 Rosado JA, Graves D, Sage SO.. Tyrosine kinases activate store-mediated Ca²⁺ entry in human platelets through the reorganization of the actin cytoskeleton. Biochem J 2000; 351: 429-37.
• 53 Ohmori T, Yatomi Y, Wu Y.. et al. Wheat germ agglutinin-induced platelet activation via platelet endothelial cell adhesion molecule-1: involvement of rapid phospholipase C gamma 2 activation by Src family kinases. Biochemistry 2001; 40: 12992-3001.
• 54 Mitscher LA, Jung M, Shankel D.. et al. Chemoprotection: a review of the potential therapeutic antioxidant properties of the green tea (Camellia sinensis) and certain of its constituents. Med Res Rev 1997; 17: 327-65.
• 55 Guo Q, Zhao B, Shen S.. et al. ESR study on the structure-antioxidant activity relationship of tea catechins and their epimers. Biochem Biophys Acta 1999; 1427: 13-23.